Taiwan · Delayed Price · Currency is TWD Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 3.75 billion. The enterprise value is 4.14 billion.
| Market Cap | 3.75B |
| Enterprise Value | 4.14B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Mar 27, 2025 |
Share Statistics
Synbio Tech has 31.40 million shares outstanding.
| Current Share Class | 31.40M |
| Shares Outstanding | 31.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 24.54% |
| Owned by Institutions (%) | n/a |
| Float | 13.27M |
Valuation Ratios
The trailing PE ratio is 33.21 and the forward PE ratio is 18.69.
| PE Ratio | 33.21 |
| Forward PE | 18.69 |
| PS Ratio | 4.56 |
| PB Ratio | 3.98 |
| P/TBV Ratio | 4.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 17.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.82, with an EV/FCF ratio of -36.50.
| EV / Earnings | 36.53 |
| EV / Sales | 5.03 |
| EV / EBITDA | 18.82 |
| EV / EBIT | 28.94 |
| EV / FCF | -36.50 |
Financial Position
The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.78.
| Current Ratio | 3.10 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | -6.46 |
| Interest Coverage | 21.68 |
Financial Efficiency
Return on equity (ROE) is 12.31% and return on invested capital (ROIC) is 5.58%.
| Return on Equity (ROE) | 12.31% |
| Return on Assets (ROA) | 5.02% |
| Return on Invested Capital (ROIC) | 5.58% |
| Return on Capital Employed (ROCE) | 8.47% |
| Revenue Per Employee | 8.95M |
| Profits Per Employee | 1.23M |
| Employee Count | 92 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.66 |
Taxes
In the past 12 months, Synbio Tech has paid 33.80 million in taxes.
| Income Tax | 33.80M |
| Effective Tax Rate | 22.98% |
Stock Price Statistics
The stock price has increased by +69.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +69.29% |
| 50-Day Moving Average | 102.09 |
| 200-Day Moving Average | 83.50 |
| Relative Strength Index (RSI) | 50.73 |
| Average Volume (20 Days) | 1,742,951 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 823.30 million and earned 113.27 million in profits. Earnings per share was 3.60.
| Revenue | 823.30M |
| Gross Profit | 418.75M |
| Operating Income | 142.96M |
| Pretax Income | 147.07M |
| Net Income | 113.27M |
| EBITDA | 215.04M |
| EBIT | 142.96M |
| Earnings Per Share (EPS) | 3.60 |
Balance Sheet
The company has 346.74 million in cash and 731.77 million in debt, giving a net cash position of -385.03 million or -12.26 per share.
| Cash & Cash Equivalents | 346.74M |
| Total Debt | 731.77M |
| Net Cash | -385.03M |
| Net Cash Per Share | -12.26 |
| Equity (Book Value) | 942.97M |
| Book Value Per Share | 30.03 |
| Working Capital | 419.36M |
Cash Flow
In the last 12 months, operating cash flow was 213.93 million and capital expenditures -327.29 million, giving a free cash flow of -113.36 million.
| Operating Cash Flow | 213.93M |
| Capital Expenditures | -327.29M |
| Free Cash Flow | -113.36M |
| FCF Per Share | -3.61 |
Margins
Gross margin is 50.86%, with operating and profit margins of 17.36% and 13.76%.
| Gross Margin | 50.86% |
| Operating Margin | 17.36% |
| Pretax Margin | 17.86% |
| Profit Margin | 13.76% |
| EBITDA Margin | 26.12% |
| EBIT Margin | 17.36% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.97, which amounts to a dividend yield of 4.16%.
| Dividend Per Share | 4.97 |
| Dividend Yield | 4.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 54.28% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.16% |
| Earnings Yield | 3.02% |
| FCF Yield | -3.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 2.78 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 4 |